TP53 and phyllodes tumor: A previous comprehensive genomic profiling study of 24 phyllodes tumors revealed a high frequency of TP53 mutations and identified potentially targetable alterations in some cases, including KIAA1549-BRAF fusion and FGFR3-TACC3 fusion, emphasizing the importance of genomic testing [12].